Spinal Cord Stimulation and the Pregnant Patient-Specific Considerations for Management: A Case Series and Review of the Literature

Objectives:  The use of spinal cord stimulation (SCS) is a form of neuromodulation used to treat chronic pain in those patients who are refractory to conventional medical management. Not uncommonly, SCS can dramatically improve a patient's quality of life, and those who are in the childbearing...

Full description

Saved in:
Bibliographic Details
Published inNeuromodulation (Malden, Mass.) Vol. 13; no. 4; pp. 270 - 274
Main Authors Bernardini, Donald J., Pratt, Stephen D., Takoudes, Tamara C., Simopoulos, Thomas T.
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.10.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives:  The use of spinal cord stimulation (SCS) is a form of neuromodulation used to treat chronic pain in those patients who are refractory to conventional medical management. Not uncommonly, SCS can dramatically improve a patient's quality of life, and those who are in the childbearing years may go on to become pregnant. The purpose of this case series is to describe: 1) implantation considerations in women of childbearing age; 2) use of rechargeable systems; 3) the obstetric and anesthetic concerns in patients with spinal cord stimulators; 4) risks of using SCS in the peripartum period. Materials and Methods:  Two female patients with complex regional pain syndrome I (CRPS I) who were well managed with SCS became pregnant. In both patients, the leads were placed through the T12/L1 interspace and the generator was placed in the buttock region. In the first patient, the device was deactivated prior to conception and maintained off for the duration of the pregnancy. The second patient became pregnant on two separate occasions, with active SCS for a portion of the first trimester. During her second pregnancy, the patient elected to use of SCS at 30 weeks' gestation. Results:  The developing fetuses with intrauterine exposure to SCS were followed out for a minimum of two years and are developmentally normal. The physical presence of the device did not complicate obstetric or anesthetic care. Rechargeable SCS systems were not adversely affected when turned off for the duration of the pregnancy. Conclusion:  Implantation of SCS devices in women of childbearing years should take into account the future needs of both obstetric and anesthetic care by avoiding the abdomen and lower lumbar spine whenever possible. There was no appreciable decline of battery capacity in present day constant current rechargeable generators when deactivated for the duration of pregnancy.
Bibliography:ArticleID:NER288
istex:F7B40ADB4504F8A9EE4DB09A0832947DBCDF954F
ark:/67375/WNG-N4B8PJQV-5
http://www.wiley.com/bw/submit.asp?ref=1094‐7159&site=1
For more information on author guidelines, an explanation of our peer review process, and conflict of interest informed consent policies, please go to
Conflict of Interest
Dr. Thomas Simopoulos is a consultant for Boston Scientific and St. Jude Medical. The other authors reported no conflicts of interest.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1094-7159
1525-1403
DOI:10.1111/j.1525-1403.2010.00288.x